Xcell Therapeutics Kosdaq
Scope
Date
~
-
Mergers & Acquisitions
SM puts cash cows up for sale as conflict with founder heats up
SM Entertainment Co., mired in conflict with its founder and former Chief Producer Lee Soo-man, is seeking to sell its shares in three key arms, wor...
Feb 16, 2023 (Gmt+09:00)
-
Bio & Pharma
AIMMED’s Somzz ushers in digital therapeutic device market in Korea
South Korea’s health and drug safety authority has cleared Somzz to treat patients with sleep disorders, a dynamic move that is expected to vi...
Feb 16, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanall Biopharma invests in Interon Labs for brain disease treatments
South Korean pharmaceuticals firm Hanall Biopharma Co. is investing in Interon Laboratories, a US biotech firm that finds and develops treatments fo...
Feb 13, 2023 (Gmt+09:00)
-
Korean stock market
Individual investors in S.Korea betting on stock market's decline
Despite South Korea's Kosdaq stock market growing this month following the "January rally," individual investors in the country are still betting on...
Feb 09, 2023 (Gmt+09:00)
-
IPOs
S.Korea's InnoGene sets its public offering price at 3,000 won
InnoGene, which is seeking to be listed on the Kosdaq market at the end of this month, said on Wednesday that it has confirmed its offering price at...
Feb 09, 2023 (Gmt+09:00)
-
Upcoming IPOs
S.Korean companies in renewed push for Kosdaq listings
South Korean companies are making renewed pushes to go public this year even at the expense of reduced IPO values.Zaram Technology Inc., a chip desi...
Jan 25, 2023 (Gmt+09:00)
-
Bio & Pharma
NGeneBio's diagnostic products start to be used in clinical tests in Vietnam
South Korea's medical diagnostics company NGeneBio Co. said on Wednesday that it is expanding its business in the Southeast Asian precision diagnost...
Jan 19, 2023 (Gmt+09:00)
-
Webtoons
Webtoon company YLAB files preliminary listing review for Kosdaq
YLAB, a South Korean content company specializing in the production, distribution, and translation of webtoons, is moving to go public this year.Acc...
Jan 12, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion develops oral antibody drug with US bio company
South Korea's biopharmaceutical company Celltrion Inc. on Monday said it signed an R&D contract with US-based Rani Therapeutics on RT-111, an or...
Jan 09, 2023 (Gmt+09:00)
-
IPOs
Morning food delivery firm Oasis passes Kosdaq listing eligibility review
Oasis Corp., which operates the early morning food delivery platform "Oasis Market," said it passed the eligibility review for listing at Kosdaq mar...
Dec 30, 2022 (Gmt+09:00)
-
Korean startups
KT Investment injects $27.8 million in 20 startups this year
KT Investment said on Thursday that it invested 35 billion won ($27.8 million) in 20 startups this past year, and that six invested companies succee...
Dec 30, 2022 (Gmt+09:00)
-
IPOs
Kosdaq listings number 129, highest since 2002 IT bubble
Depression in equity markets in the wake of global rate hikes this year has not prevented Korean companies from rushing into Kosdaq, South Korea's m...
Dec 28, 2022 (Gmt+09:00)
-
Venture capital
Korea’s big bio startups to launch $39 mn investment fund
South Korea’s four leading biotech firms plan to launch an investment fund of up to 50 billion won ($39 million) to support smaller domestic b...
Dec 26, 2022 (Gmt+09:00)
-
Bio & Pharma
HLB Therapeutics signs contract for COVID vaccine distribution rights
South Korea's pharmaceutical firm HLB Therapeutics Co. said on Monday that it has signed an agreement with the Korea Disease Control and Prevention ...
Dec 20, 2022 (Gmt+09:00)
-
Bio & Pharma
New drug developer Onconic Therapeutics raises $20 mn in Series B
South Korean drug developer Onconic Therapeutics, announced on Friday that it raised 26 billion won ($19.9 million) in Series B funding, with cumula...
Dec 09, 2022 (Gmt+09:00)
-
Bio & Pharma
MDimune signs research agreement with Australian National University
MDimune, a South Korean biotech company, said on Wednesday that it had signed an agreement with the Clear Vision Research (CVR) Lab, a research grou...
Dec 07, 2022 (Gmt+09:00)
-
Venture capital
Daol Financial Group to let go of VC affiliate, hit by liquidity crunch
The Daol Financial Group is widely expected to let go of its venture capital arm in the midst of a worsening liquidity crunch. The VC firm Daol...
Dec 06, 2022 (Gmt+09:00)
-
Bio & Pharma
Korea’s Peak Bio makes Nasdaq debut via SPAC deal with Ignyte
Peak Bio Co., a South Korean biopharmaceutical company, is debuting on the Nasdaq through a merger with US blank cheque company Ignyte Acquisition C...
Oct 28, 2022 (Gmt+09:00)
-
Foreign exchange
Korean won at fresh low since global financial crisis as markets crash
The South Korean won on Monday extended losses to a fresh low since the 2008-09 financial crisis as local financial markets lost ground, alongside t...
Sep 26, 2022 (Gmt+09:00)
-
Upcoming IPOs
DRX aims to be first Korean e-sports firm to go public with 2024 IPO
South Korea’s e-sports company DRX is aiming to become the first e-sports firm to list on the secondary bourse Kosdaq with its planned 2024 IP...
Sep 08, 2022 (Gmt+09:00)
-
Bio & Pharma
Precision Biosensor enters Italy with chemical test kits
South Korea’s diagnostic devices supplier Precision Biosensor Inc. has signed an export contract with Italian medical device company Borden Ch...
Sep 01, 2022 (Gmt+09:00)
-
Bio & Pharma
SK Discovery to control affiliates’ entire biotechnology business
SK Discovery Co., an intermediate holding company of South Korea’s third-largest conglomerate SK Group, will take charge of the entire biotech...
Aug 05, 2022 (Gmt+09:00)
-
Korean games
Korea's top mobile game Odin creator Lionheart eyes IPO in H2
Lionheart Studio Corp., South Korea’s leading game developer behind the mobile game Odin, has begun the process to go public with its July 22 ...
Jul 24, 2022 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics to double CDMO capacity with new plants worth $5.3 bn
Samsung Biologics Co., the world’s largest contract drugmaker, plans to double its manufacturing capacity by building four additional plants w...
Jul 18, 2022 (Gmt+09:00)
-
Bio & Pharma
Korean biotech firms fold COVID-19 therapeutics development businesses
A string of South Korean pharmaceutical and biotech companies are waving the white flag when it comes to developing COVID-19 treatments. As the...
Jul 04, 2022 (Gmt+09:00)
-
Metaverse
Shinsegae to build metaverse presence with Hancom
South Korea’s retail powerhouse Shinsegae Inc. will kickstart its efforts to build a metaverse presence, while seeking to buy a stake in its d...
Jun 23, 2022 (Gmt+09:00)
-
Bio & Pharma
KT, Hanmi-invested therapeutics maker Digital Pharm launched
Digital Pharm, jointly invested in by KT Corp. and Hanmi Pharmaceutical Co., held an official inauguration ceremony last week, the company announced...
Jun 20, 2022 (Gmt+09:00)
-
Bio & Pharma
SK invests in US digital healthcare firm Cala Health
South Korea's SK Biopharmaceuticals Co. has dipped its toes into the rapidly growing digital healthcare market by investing in Cala Health, a US-bas...
May 19, 2022 (Gmt+09:00)
-
Korean startups
Korean drone manufacturer aims for 2023 Kosdaq IPO
South Korea's commercial drone manufacturer Nearthlab plans to apply for an initial public offering this year to get listed on the junior Kosdaq mar...
Feb 17, 2022 (Gmt+09:00)
-
Mergers & Acquisitions
Samsung buys $2.3 bn Bioepis stake from Biogen to end partnership
Samsung Biologics Co. is acquiring a nearly 50% stake in a biosimilar joint venture with Biogen Inc. from the US biotechnology company for $2.3 bill...
Jan 28, 2022 (Gmt+09:00)
language
Latest News
- 1 Bain Capital puts beauty device maker Classys on market
- 2 POSCO International eyes M&A in US natural gas market
- 3 Samsung Galaxy Z Fold Special Edition: slimmest, lightest of its kind
- 4 Hyundai Motor Group six affiliates to strengthen carbon neutrality
- 5 Samsung C&T consortium wins $1.6 bn Turkish highway project